My watch list  

Chemel AB (publ) develops, manufactures and sells biochemical analysis systems based on the SIRE® technology including instrument, reagents, service and software. The end-users are biotech and food industries. Furthermore, the company develops clinical applications, initially in the field of blood glucose analysis.

Our vision is a successful Swedish biotech company with global sales of high quality analysis products. Our goal is to be regarded as a competent and reliable provider of analysis solutions in well-defined food and bioprocess applications. Further goals involve development of clinical diagnostic tools and licensing of the SIRE® Technology in niche-areas where the company does not have the intention to explore the SIRE® Technology itself.

Chemel shall develop high quality products and offer complete solutions for user-friendly, specific, flexible and rapid analysis in complex sample solutions to its customers. The products will be marketed by Chemel itself and through well-renown distributors or other types of partners globally. The SIRE® Technology will be developed by Chemel itself or, if technically and economically favourable, together with partners.

More about Biotech-IgG
  • Companies

    Biotech-IgG A/S

    Biotech-IgG was formed in 1989 to provide the Scandinavian biotechnology and medical immunodiagnostics markets with high quality products for research, routine and process scale purposes. The company is based close to the centre of Copenhagen, Denmark, and is located only a few minutes awa ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE